ID	Database	Citation
23631851	Pubmed	"The fatty acid receptor FFA1/GPR40 a decade later: how much do we know? Mancini AD, Poitout V. Trends Endocrinol Metab. 2013 Aug;24(8):398–407.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/23631851"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/23631851"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/23631851"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
24051395	Pubmed	"Modulating GPR40: therapeutic promise and potential in diabetes. Poitout V, Lin DCH. Drug Discov Today. 2013 Dec;18(23–24):1301–8.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/24051395"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/24051395"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/24051395"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
